AEGiS-Reuters: Sex-Disease Chlamydia Rife Among Japanese Teens

Reuters, Ltd.Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


Sex-Disease Chlamydia Rife Among Japanese Teens

Reuters NewMedia - December 2, 2004


TOKYO (Reuters) - More than 10 percent of Japanese teenagers who were screened for a sexual disease that can cause infertility tested positive, a newspaper reported, adding to concerns about increasing sexual activity among Japan's youth.

An average of 11.4 percent of high school students on the main northern island of Hokkaido tested positive for chlamydia, an infection which often displays no symptoms, the Yomiuri Shimbun daily reported on Thursday.

The screening, led by Hirohisa Imai, a doctor at Asahikawa Medical University, targeted 3,190 male and female students at 13 high schools in Hokkaido, whose patterns of teen sexual activity mirror those of the nation as a whole, the Yomiuri said.

Chlamydia can cause ectopic pregnancy and infertility in women, and urethritis and testicular swelling in men.

Some 20 to 30 percent of Japanese 16-year-olds have had sex, and nearly a quarter of these have had four or more partners, according to Masako Kihara, an AIDS expert and associate professor at Kyoto University.

Kihara said she was unaware of the survey but that the figure of 10 percent did not particularly surprise her, given that chlamydia is the most prevalent sexual disease among teenagers.

"If it really is spreading this fast, it shows that there's a lot of unprotected sex going on, and that other sexual diseases could also be spread," she said.

Of particular concern to authorities is AIDS.

In 2003, 976 new HIV/AIDS cases were reported, the highest annual figure and about a tenth of all new cases since 1985. Of new HIV cases, at least 33 percent involved people under 29.


041202
RE041212


Copyright © 2004 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .